A PROGNOSTIC MODEL to PREDICT SURVIVAL In WHO-DEFINED ESSENTIAL THROMBOCYTHEMIA: A STUDY by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

Francesco Passamonti(University of Milan), Ayalew Tefferi(Mayo Clinic), Irene Bertozzi(University of Padua), Alessandra Carobbio(Ospedale Papa Giovanni XXIII), Valentina Carrai(University of Bergamo), Filippo Marino(Università Cattolica del Sacro Cuore), François Girodon(Inserm), Domenica Caramazza(Ospedale di Circolo e Fondazione Macchi), Emanuela Boveri(Policlinico San Matteo Fondazione), Alessandro M. Vannucchi(Azienda Ospedaliero-Universitaria Careggi), Heinz Gisslinger(Medical University of Vienna), Mario Cazzola(Roche (Switzerland)), Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Hans Michael Kvasnicka(Helios Universitätsklinikum Wuppertal), Andrea Gianatti(University of Bergamo), Cristiana Pascutto(University of Pavia), Tiziano Barbui(University of Bergamo), Elisa Rumi(University of Pavia), Elisabetta Antonioli(Azienda Ospedaliero-Universitaria Careggi), Bettina Gisslinger(Medical University of Vienna), Marco Ruggeri(Ospedale San Bortolo), Margherita Maffioli, Curtis A. Hanson(Toyota Motor Corporation (Switzerland)), Jüergen Thiele(University of Cologne), Emanuele S.G. dʼAmore(Ospedale San Bortolo), M. L. Randi(University of Padua), Leonhard Müllauer(Hochschule Campus Wien), Francesco Rodeghiero(Ospedale San Bortolo), Naseema Gangat(Mayo Clinic in Arizona)
Blood
November 18, 2011
Cited by 5


Related Papers